December 1, 2016 / 9:55 PM / 8 months ago

BRIEF-Protalix Biotherapeutics announces private placement of secured convertible notes due 2021

1 Min Read

Dec 1 (Reuters) - Protalix Biotherapeutics Inc

* Protalix biotherapeutics announces private note exchanges and private placement of secured convertible notes due 2021

* Protalix biotherapeutics says entered into definitive exchange agreement to exchange $54.1 million of outstanding 4.50% senior convertible notes due 2018

* Protalix biotherapeutics inc says exchange agrrement for $40.2 million principal amount of newly issued 7.50% senior secured convertible notes due 2021

* Protalix biotherapeutics inc says exchange agrrement for approximately 23.8 million shares of common stock, $0.001 par value per share

* Protalix biotherapeutics-entered into definitive note purchase agreement with commitments to issue, sell $22.5 million principal amount of notes due 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below